Published in Transplantation on August 15, 1995
Pilot Trial for Implementation of a MPA PK Monitoring Strategy (MPA) | NCT00187915
Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes. Diabetes Care (2010) 2.57
Long-term survival of living donor renal transplants: A single center study. Indian J Nephrol (2010) 2.17
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Myasthenia gravis. Orphanet J Rare Dis (2007) 1.81
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation (1998) 1.16
Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg (1998) 1.16
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation (1999) 1.14
Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modelling. Br J Clin Pharmacol (2005) 1.06
Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result. Clin J Am Soc Nephrol (2008) 1.06
Investigation on pharmacokinetics of mycophenolic acid in Chinese adult renal transplant patients. Br J Clin Pharmacol (2006) 1.06
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Kidney Int (2009) 1.03
Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol (2006) 1.02
[Immunomodulation in penetrating keratoplasty. Current status and perspectives]. Ophthalmologe (2003) 1.00
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9. Br J Clin Pharmacol (2008) 0.99
Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg (1996) 0.98
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD. Bone Marrow Transplant (2009) 0.97
Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits. Am J Transplant (2009) 0.96
Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol (2007) 0.96
Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Infect Dis (2009) 0.95
Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil. Br J Clin Pharmacol (2003) 0.95
Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol (2008) 0.94
Autoimmune Myasthenia Gravis: Recommendations for Treatment and Immunologic Modulation. Curr Treat Options Neurol (2005) 0.89
Time-dependent clearance of mycophenolic acid in renal transplant recipients. Br J Clin Pharmacol (2007) 0.88
Mycophenolate mofetil monotherapy in the management of paediatric uveitis. Eye (Lond) (2011) 0.88
Therapy of lupus nephritis: lessons learned from clinical research and daily care of patients. Arthritis Res Ther (2012) 0.87
Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series. Int Ophthalmol (2009) 0.86
Pharmacokinetic and pharmacodynamic analysis of enteric-coated mycophenolate sodium: limited sampling strategies and clinical outcome in renal transplant patients. Br J Clin Pharmacol (2010) 0.86
Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. Br J Clin Pharmacol (2005) 0.85
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. Clin Transpl (1995) 0.85
Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients. Clin J Am Soc Nephrol (2010) 0.84
Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome. Pediatr Nephrol (2010) 0.83
Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen. Int Immunopharmacol (2011) 0.83
Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83
A review on therapeutic drug monitoring of immunosuppressant drugs. Iran J Basic Med Sci (2011) 0.83
Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment. J Virol (2004) 0.82
Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy. Can J Gastroenterol (2010) 0.82
Mycophenolate mofetil: emerging as a potential human teratogen. Can Fam Physician (2008) 0.82
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil. Pharmacogenet Genomics (2010) 0.82
Clinically useful monoclonal antibodies in treatment. J Clin Pathol (2002) 0.82
The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase. J Am Soc Nephrol (2010) 0.82
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus. Arthritis Res Ther (2012) 0.82
Urine Metabolite Profiles Predictive of Human Kidney Allograft Status. J Am Soc Nephrol (2015) 0.81
Antibody induction therapy in adult kidney transplantation: A controversy continues. World J Transplant (2012) 0.81
Is newer safer? Adverse events associated with first-line therapies for ANCA-associated vasculitis and lupus nephritis. Clin J Am Soc Nephrol (2014) 0.81
Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. J Am Soc Nephrol (2015) 0.81
Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies. Eur J Clin Pharmacol (2006) 0.81
[Statement on the use of mycophenolate mofetil for systemic lupus erythematosus]. Z Rheumatol (2013) 0.80
Mycophenolate mofetil is effective in reducing lupus glomerulonephritis proteinuria. Rheumatol Int (2006) 0.80
Antihypertensive agents and renal transplantation. Hippokratia (2007) 0.80
A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res (2014) 0.80
To what extent does the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription. Pediatr Nephrol (2004) 0.80
Time dependent neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation. J Neuroinflammation (2012) 0.79
Update on the Teratogenicity of Maternal Mycophenolate Mofetil. J Pediatr Genet (2015) 0.79
Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl (1998) 0.78
Pancreas and islet cell transplantation. Best Pract Res Clin Gastroenterol (2002) 0.78
Ulcerative colitis after renal transplantation: A case report and review of literature. Indian J Nephrol (2011) 0.78
Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy. J Transplant (2013) 0.78
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report. Transplantation (2001) 0.78
Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection. Ther Clin Risk Manag (2009) 0.78
Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5'-monophosphate dehydrogenase II (IMPDH II) inhibitors. J Comput Aided Mol Des (2012) 0.78
New immunosuppressive drugs and lung transplantation: last or least? Thorax (1999) 0.77
Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient. Clin Exp Nephrol (2008) 0.76
Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability. Ther Clin Risk Manag (2009) 0.76
[Revision of the recommendations of the Commission on Pharmacotherapy of the German Society for Rheumatology. Comment on the use of mycophenolic acid for systemic lupus erythematosus]. Z Rheumatol (2007) 0.76
Safety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation. Clin Transplant (2012) 0.76
Renal Transplantation - An Experience of 500 Patients. Med J Armed Forces India (2011) 0.75
The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu's arteritis. Sci Rep (2016) 0.75
Virtual high-throughput screening identifies mycophenolic acid as a novel RNA capping inhibitor. PLoS One (2011) 0.75
Acute pancreatitis induced by mycophenolate mofetil in a kidney transplant patient. J Nephropharmacol (2015) 0.75
The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors. Arab J Urol (2012) 0.75
Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients. Int J Nephrol Renovasc Dis (2010) 0.75
The influence of mycophenolate mofetil and azathioprine on the same cadaveric donor renal transplantation. J Korean Med Sci (2005) 0.75
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. BMC Med Genomics (2014) 0.75
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol (1998) 0.75
Mycophenolate mofetil-induced oral ulcerations in solid organ transplant recipients: A report of 3 cases. JAAD Case Rep (2015) 0.75
Renal Transplantation: Experience at a Single Centre. Med J Armed Forces India (2011) 0.75
Prevalence and management of post-transplant anemia in long-term follow-up of Chinese kidney transplant recipients: a single-center report. Eur J Med Res (2013) 0.75
Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry. Clin Transplant (2012) 0.75
West Meets East. Kidney Dis (Basel) (2015) 0.75
Extensive herpes zoster involvement following mycophenolate mofetil therapy for sarcoidosis. J Ophthalmic Inflamm Infect (2011) 0.75
The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room. J Clin Aesthet Dermatol (2011) 0.75
Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms. Pharmgenomics Pers Med (2014) 0.75
Efficacy and safety of immunosuppressive drugs approved in EU through the centralised procedure. Eur J Clin Pharmacol (2007) 0.75
Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy. Pediatr Nephrol (2003) 0.75